Jefferies analyst Brian Tanquilut says HCA Healthcare shares are now oversold amid the Medicare-For-All "noise." The analyst expects volatility in the stocks of healthcare providers before the November 2020 elections, but he believes the emergence of Medicare for All "as an early hot topic has brought volatility/noise prematurely." HCA is now oversold based on a valuation analysis that looks at previous election cycles, especially since Medicare-For-All does not pose existential risk to the hospitals, Tanquilut tells investors in a research note. As currently proposed, Medicare-For-All will most likely reduce the need for managed care companies, but the need for healthcare providers does not go away, as the government will need hospitals, physician practices, and other providers to remain viable to protect access to care, says the analyst. He keeps a Buy rating on HCA Healthcare with a $158 price target.

Catheter Precision (VTAK) has received its first purchase order for LockeT from an HCA Healthcare (HCA) facility.

Augmedix (AUGX) announced the general availability of Augmedix Go for emergency departments, marking the launch of the industry's first fully-automated, generative AI powered medical documentation product for EDs across the country. The launch incorporates learnings from a pilot program with HCA Healthcare (HCA), one of the nation's leading healthcare providers. As part of the pilot, ED physicians in four HCA Healthcare hospitals utilized Augmedix Go to automate medical documentation, with the product instantaneously drafting their medical notes from patient visits. "The launch of Augmedix Go in the ED represents our unwavering commitment to develop solutions for health systems that improve their workflows. Our agility and flexible architecture, exhibited by our broad product suite and open network platform, help us address the complex and varying needs of clinicians and providers," said Manny Krakaris, CEO of Augmedix. "We have built a sophisticated platform designed to enable clinicians to be present with their patients while trusting that Augmedix technology is doing administrative work unobtrusively in the background."